https://rjrindex.com/articles/temperature-controlled-hand-foot-cooling-for-prevention-of-chemotherapy-induced-polyneuropathy-cipn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-head-and-neck-cancers-in-syria-an-analysis-from-the-national-oncology-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-diagnosis-to-survivorship-mapping-the-lived-experience-of-patients-with-cancer-in-the-philippi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-care-in-head-and-neck-squamous-cell-carcinoma-a-retrospective-analysis-at-a-safet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-a-psychosocial-oncology-consult-service-pre-post-a-one-session-educational-interventi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-surrogate-endpoints-in-health-technology-assessment-a-review-of-company-submissions-for-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reinforce-a-phase-iii-randomized-trial-of-treatment-intensification-with-docetaxel-in-metastatic-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-lung-cancer-burden-attributable-to-environmental-and-occupational-exposures 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-survival-in-356-patients-failing-frontline-hma-ven-for-newly-diagnosed-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-experience-and-quality-of-life-in-a-decentralized-cancer-care-model-for-advanced-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-access-to-molecular-diagnostics-and-immunotherapy-for-advanced-melanoma-in-syria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamics-of-tissue-fatty-acid-profiles-and-association-with-radiotherapy-toxicity-in-locally-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-eligibility-for-perioperative-pembrolizumab-in-resectable-locally-advanced-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-mortality-following-unplanned-breast-cancer-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-mrna-covid-19-vaccination-on-survival-in-pembrolizumab-treated-stage-iv-colon-cancer-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-nicotine-delivery-systems-versus-combustible-cigarettes-a-systematic-review-and-meta-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uterine-cancer-mortality-and-demographic-disparities-in-the-united-states-in-relation-to-female-obes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-preventable-cancer-with-unequal-outcomes-cervical-cancer-disparities-in-wisconsin-2014-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-prevalence-in-ohio-rural-urban-differences-environmental-toxicity-and-correlation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-esophageal-cancer-and-respiratory-failure-mortality-among-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-immune-checkpoint-inhibitors-on-treatment-results-in-cancer-patients-real-world-ev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-combination-versus-single-agent-immune-checkpoint-inhibition-in-locally-advanced-msi-hd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-gedatolisib-geda-pharmacokinetics-pk-drug-drug-interactions-ddi-and-exposure-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-triplet-therapy-with-hypomethylating-agent-venetoclax-and-flt3-inhibitor-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-real-time-updated-evidence-library-in-addressing-lag-in-guideline-updates-to-aide-physic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-in-imeti-ex14-nsclc-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-in-combination-with-cetuximab-and-chemotherapy-as-first-line-treatment-for-microsatellite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-quality-improvement-initiative-to-improve-genomic-testing-rates-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-among-patients-with-high-risk-and-very-high-risk-non-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-mat2a-mediated-metabolic-pathways-a-novel-strategy-for-non-small-cell-lung-cancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-contributing-to-non-initiation-of-planned-systemic-therapy-among-inpatients-evaluated-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-the-tumor-microenvironment-in-primary-versus-metastatic-lymph-node-malignanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-landscape-of-early-onset-colorectal-cancer-a-comparative-analysis-with-averag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-malignant-neoplasms-and-alzheimers-disease-related-mortality-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/popliteal-node-metastasis-in-infra-popliteal-melanoma-arcane-or-mundane 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-prevalence-co-occurrence-and-descriptive-analysis-of-esr1-and-pik3ca-mutations-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-use-at-the-end-of-life-among-medicare-decedents-with-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-multidisciplinary-therapy-combining-local-ablative-therapy-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tigos-ls-an-open-label-randomized-study-of-bms-986489-atigotatug-nivolumab-fixed-dose-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clarity-gbm-a-phase-ii-multi-centered-open-label-single-arm-study-to-evaluate-the-safety-and-eff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-monitoring-in-peptide-receptor-radionuclide-therapy-treated-patients-with-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-zeaxanthin-alone-or-in-combination-with-pembrolizumab-in-metastatic-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-inpatient-incidence-of-head-and-neck-cancer-and-anatomic-subsites-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/menopausal-hormone-therapy-use-and-counseling-patterns-among-surgically-menopausal-brca-mutation-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-inadequate-ovarian-suppression-in-premenopausal-breast-cancer-patients-receiving-ovarian-fu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-distribution-of-international-cancer-research-funding 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-full-dose-apixaban-vs-rivaroxaban-for-cancer-associated-venous-thromboembolis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-enabled-framework-for-pre-visit-decision-support-using-patient-similarity-analysis-in-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-actionability-and-molecular-landscapes-of-fusion-driven-sarcomas-a-multi-modal-integration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-study-of-itp53i-mutations-in-circulating-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-pharmacovigilance-analysis-of-adverse-events-associated-with-zanidatamab-versus-trastuzu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dont-ask-dont-tell-missing-ecogs-and-anticancer-treatment-neutrophil-to-lymphocyte-ratios-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geospatial-hotspot-analysis-of-breast-cancer-in-ohio-environmental-and-rural-urban-disparities-info 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-perspectives-on-artificial-intelligence-use-in-cancer-care-confidence-adoption-and-barri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-rurality-on-screening-and-prevention-strategies-for-patients-with-hereditary-breast-and-ov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-patient-care-in-oncology-nationwide-results-of-comprehensive-genomic-profiling-guided 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-health-record-based-gut-disruption-and-perfluoroalkyl-and-polyfluoroalkyl-substances-drin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-myelodysplastic-syndrome-and-acute-myeloid-leukemia-among-hospitalizations-with-sickle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deficiencies-in-oncology-marketing-applications-leading-to-fda-rejections-an-assessment-of-complete 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-onco-critical-care-management-clinical-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-lymphoid-and-hematopoietic-malignancies-among-us-adults-a-cdc-wonder-based-dem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-patient-priorities-for-survivorship-care-in-older-adults-with-cancer-a-collaborative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-diasurv-an-ai-based-algorithm-for-stage-ii-colon-cancer-risk-stratification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-a-personalized-cancer-vaccine-in-combination-with-immune-checkpoint-inhibitor-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-prostate-cancer-mortality-among-men-with-hypertension-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibiotics-and-immune-related-toxicity-during-pembrolizumab-therapy-in-nsclc-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhaled-delivery-of-kb707-a-novel-hsv-based-immunotherapy-in-combination-with-pembrolizumab-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-bma-improve-outcomes-in-mhspc-with-bone-metastases-landmark-propensity-matched-analysis-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-ubenimex-combined-with-pembrolizumab-nab-paclitaxel-and-carboplatin-for-previo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-pneumonitis-risk-after-chemoradiation-and-durvalumab-by-chemotherapy-regimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-dependent-features-of-primary-non-small-cell-lung-cancer-course-in-patients-with-previous-covid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-multi-center-single-arm-study-of-atezolizumab-and-bevacizumab-in-the-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-volumetric-vs-bidimensional-rano-20-progression-assessment-prognostic-value-for-overall-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-immune-profiling-to-identify-gpnmb-as-a-mediator-of-immune-suppression-that-limits-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carcinomas-of-unknown-primary-treated-with-molecularly-guided-therapies-and-immune-checkpoint-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-compared-with-platinum-based-chemotherapy-in-bladder-cancer-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-pembrolizumab-efficacy-and-safety-in-patients-with-nsclc-with-high-pd-l1-expr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-tumor-dna-as-a-biomarker-of-pathologic-response-and-molecular-residual-disease-in-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-burden-reduction-after-two-doses-of-cemiplimab-in-advanced-non-melanoma-skin-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-stage-iibiic-cutaneous-melanoma-treated-with-wide-local-excision-and-adjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-northstar-ctdna-assay-for-monitoring-gastrointestinal-malignancies-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-neoadjuvant-chemotherapy-matter-in-endocrine-sensitive-breast-cancer-insights-from-a-10-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-treatment-sequencing-matter-in-stage-iv-nsclc-with-brain-metastases-a-national-cancer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-engineered-tcr-t-cell-therapy-afami-cel-lete-cel-in-pediatric-synovial-sar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-delayed-sodium-thiosulfate-on-cisplatin-induced-ototoxicity-in-pediatric-and-adolescent-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-basket-trial-of-brigatinib-for-ialki-fusion-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erythropoietin-receptor-epor-expression-to-identify-a-biologically-aggressive-tumor-phenotype-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-immune-and-cardiopulmonary-toxicities-of-durvalumab-following-concurrent-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-potentially-inappropriate-medications-on-performance-status-functional-status-and-ov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-combined-with-t-dxd-in-her2-positive-metastatic-gastric-gastroesophageal-junction-or-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decision-making-and-regret-after-radical-cystectomy-in-patients-with-bladder-cancer-an-internationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/convenience-vs-complexity-adoption-of-subcutaneous-pd-l1s-in-lung-cancer-in-eu4uk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prion-like-dynamics-of-galectin-3-as-a-driver-of-colorectal-cancer-progression-a-digital-pathology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/statistical-data-and-mortality-rates-for-prostate-cancer-from-1999-to-2021-in-the-population-of-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-diabetes-and-glycemic-control-on-pathologic-complete-response-after-neoadjuvant-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muc5ac-driven-transcriptional-reprogramming-for-stratification-of-pancreatic-ductal-adenocarcinoma-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-prostate-cancer-screening-in-germline-pathogenic-variant-carriers-the-patrol-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-bispecific-antibodies-in-relapsedrefractory-rr-follicular-lymphoma-fl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keynote-811-6-year-median-follow-up-of-pembrolizumab-plus-trastuzumab-and-chemotherapy-for-previous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-folfirinox-ffx-combined-with-the-glycogen-synthase-kinase-3beta-gsk-3v-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-integrated-multidisciplinary-analysis-of-pre-treatment-cachexia-in-locally-advanced-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-antibody-drug-conjugate-target-expression-in-epithelial-ovarian-cancer-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azeliragon-a-rage-inhibitor-plus-temozolomide-and-radiotherapy-in-patients-with-newly-diagnosed-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enabling-hybrid-ai-radiologist-endpoints-in-clinical-trials-imaging-workflows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ea1181-accuracy-of-pre-surgery-mri-to-predict-pathologic-complete-response-after-taxane-trastuzuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-between-neoadjuvant-and-adjuvant-chemo-immunotherapy-in-patients-with-stage-ii-iii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-vulnerability-among-us-cancer-survivors-differences-by-veteran-status-and-va-health-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-response-with-survival-in-patients-with-relapsedrefractory-high-risk-neuroblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genetic-landscape-of-individuals-evaluated-in-a-chip-cardiology-clinic-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-aspirin-and-structured-exercise-as-adjuvant-therapy-in-localized-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-plus-cetuximab-and-irinotecan-in-relapsedrefractory-rasbraf-wild-type-and-microsatell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-yes-an-mhealth-intervention-for-adolescent-and-young-adults-aya-with-breast-cancer-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-resistance-to-prior-car-t-therapy-efficacy-and-safety-of-a-sequential-multi-antigen-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-incidence-and-predictors-of-chronic-opioid-use-in-early-survivorship-for-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-stratification-using-baseline-objective-clinical-information-in-patients-with-stage-iv-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-caused-by-coexisting-malignant-neoplasms-and-type-2-diabetes-mellitus-in-us-adults-a-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fitbit-derived-activity-and-heart-rate-patterns-for-predicting-12-month-hospitalization-in-an-nih-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-predictors-of-treatment-response-in-the-bounce-back-mind-body-resiliency-trial-for-aya-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/format-matters-digital-vs-print-delivery-of-a-job-retention-intervention-during-breast-cancer-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-access-to-tyrosine-kinase-inhibitors-for-treatment-of-philadelphia-chromosome-positive-acu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimation-of-the-impact-of-chemotherapy-induced-biological-age-acceleration-on-breast-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-diffusion-on-low-rank-approximation-radiomic-phenotypes-with-deep-learning-survival-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-alternative-approach-to-limiting-surgical-and-radiation-stress-in-patients-with-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-neoadjuvant-chemoradiotherapy-response-and-postoperative-recurrence-in-locally-advanced-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-the-nutripal-nutritional-screening-algorithm-in-advanced-cancer-palliative-care-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-converge-study-a-phase-ii-single-arm-trial-of-adebelimab-combined-with-targeted-therapy-and-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-performance-of-an-ai-based-recurrence-score-in-early-breast-cancer-patients-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-low-and-high-grade-icans-after-car-t-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-diabetes-mellitus-on-inpatient-outcomes-among-hospitalized-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monoclonal-gammopathy-associated-autoinflammation-a-systematic-review-and-meta-analysis-of-schnitzl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-antitumor-effect-of-2-11-dimethyl-1h-benzoeindol-2-yl-567-trichloro-13-tro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/firmonertinib-combined-with-platinum-based-chemotherapy-in-patients-with-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consideration-of-adjusted-ideal-body-weight-dosing-in-bg-c9074-b7-h4-targeting-adc-from-pharmacoki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-pixel-to-precision-a-systematic-review-of-ct-radiomics-in-the-diagnosis-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-cardiovascular-and-cerebrovascular-mortality-among-us-decedents-with-malignant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-of-ctx-8371-a-novel-pd-1pd-l1-bispecific-antibody-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-5-year-survival-outcomes-of-short-course-radiation-followed-by-mfolfox-6-plus-avelumab-in-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-trastuzumab-emtansine-t-dm1-combined-with-ribociclib-in-patients-with-her2-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-recovery-patterns-among-patients-with-early-stage-cancer-who-develop-taxane-induced-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-vt-ebv-n-on-disease-free-survival-as-post-remission-therapy-in-ebv-positive-extranodal-nk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-itonsli-on-tumor-suppressor-function-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-foxm1-in-regulating-immune-memory-in-triple-negative-breast-cancer-and-targeting-foxm1-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-driven-assessment-of-immunochemotherapy-with-or-without-fruquintinib-as-first-line-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/copy-number-aberration-profiling-using-shallow-whole-genome-sequencing-based-leukoprint-in-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrocabosarc-a-phase-ii-trial-combining-pembrolizumab-and-cabozantinib-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-a-statewide-intervention-on-multiple-myeloma-bispecific-t-cell-engaging-ant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-2026-primary-care-oncology-toolkit-an-evolving-shared-care-framework-for-the-implementation-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-resection-versus-stereotactic-body-radiation-therapy-in-stage-iv-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-niraparib-maintenance-on-progression-free-survival-and-overall-survival-an-updated-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monalizumab-plus-durvalumab-plus-platinum-based-chemotherapy-for-first-line-treatment-of-extensive-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fluorescence-guided-surgery-with-5-aminolevulinic-acid-5-ala-in-ovarian-fallopian-tube-and-prima 2026-08-24 monthly 0.7 https://rjrindex.com/articles/listening-explaining-caring-patient-experience-in-an-oncology-primary-care-clinic-background 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impactof-imeti-amplification-amp-on-telisotuzumab-ved 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-and-patterns-of-recurrence-for-patients-pts-with-advanced-urothelial-carcinoma-auc-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-for-pretreated-patients-in-china-with-her2-ihc-3-solid-tumors-desti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-ipilimumab-nivolumab-dosing-strategies-in-melanoma-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ialox12bi-gene-alterations-with-tmb-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shared-treatment-decision-making-between-physicians-and-their-patients-with-metastatic-urothelial-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-engage-program-for-childhood-cancer-survivors-results-from-a-multidisciplinary-distance-delive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smoking-signature-as-used-to-define-a-genomically-distinct-subset-of-class-i-braf-mutant-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-immune-effects-of-enfortumab-vedotin-and-pembrolizumab-evp-on-peripheral-blood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-aspirin-and-anticoagulant-prophylaxis-at-imid-associated-vte-onset-in-multipl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-and-survival-trends-of-adjuvant-immunotherapy-in-postoperative-stage-ii-iii-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-homologous-recombination-repair-deficiencies-in-prostate-cancer-in-the-russian-federat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-and-temporal-trends-of-first-line-immunotherapy-use-in-metastatic-nsclc-in-brazi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/terminal-admission-phenotype-in-acute-myeloid-leukemia-a-national-analysis-of-inpatient-care-intens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-multicenter-phase-3-study-of-rp1-vusolimogene-oderparepvec-combined-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-neoadjuvant-pembrolizumab-among-patients-with-early-stage-triple-neg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ngs-based-idpydi-diplotype-analysis-beyond-conventional 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-cancer-related-mortality-among-adults-with-diabetes-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-functional-precision-medicine-strategy-to-guide-patient-selection-for-oncolytic-vaccination-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-facility-type-on-outcomes-for-elderly-patients-75-years-with-burkitt-lymphoma-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-cellular-senescence-to-enhance-skeletal-muscle-recovery-in-survivors-of-breast-cancer-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibitor-plus-vegfr-2-inhibitor-and-chemotherapy-versus-chemotherapy-alone-for-locally-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-meaning-and-purpose-among-patients-with-cancer-and-with-elevated-psychological-distres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-chemotherapy-and-central-nervous-system-relapse-in-acute-lymphoblastic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-erythrocytosis-on-overall-survival-thrombotic-events-and-risk-of-transformation-to-aml-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-on-the-application-of-metaproteomic-and-serum-metabolomic-integration-analysis-in-tace-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-endocrine-toxicities-and-serious-outcomes-associated-with-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-double-blind-double-dummy-randomized-controlled-phase-3-trial-of-iparomlimab-and-tuvonralimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yl205-a-novel-anti-napi2b-antibody-drug-conjugate-adc-in-patients-with-ovarian-cancer-prelimina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optecoptal-a-phase-2-study-to-evaluate-outpatient-op-step-up-administration-of-teclistamab-tec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-receives-car-t-therapy-a-national-examination-of-racial-and-ethnic-differences-in-hospitalized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-as-first-line-treatment-of-ireti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-plus-pembrolizumab-evp-vs-chemotherapy-for-previously-untreated-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-first-line-folfirinox-versus-gemcitabine-plus-nab-paclitaxel-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12a-study-of-concomitant-radiotherapy-with-olaparib-and-temozolomide-in-unresectable-high-gra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-from-single-cell-rna-sequencing-profiles-of-18-cptac-glioblastoma-patients-and-validation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-multiple-myeloma-and-comorb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zopapogene-imadenovec-drba-a-novel-non-replicating-adenoviral-vector-based-immunotherapy-effects-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-clinical-utility-of-an-hampe-based-tumor-origin-prediction-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-trial-of-intravesical-yh01-for-bcg-unresponsive-high-risk-non-muscle-invasive-bl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iegfri-mutated-lung-cancer-a-comparative-analysis-of-common-and-uncommon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-11b-study-of-amg-436-as-monotherapy-and-combination-therapy-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-sintilimab-plus-bevacizumab-following-curative-resection-of-spontaneously-ruptured-hepatoce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-trial-evaluating-addition-of-adjuvant-chemotherapy-to-ovarian-function-suppression-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-dose-escalation-study-of-the-selective-egfrher2-exon-20-inhibitor-pfl-721-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-antitumor-activity-of-vrn110755-a-brain-penetrant-selective-egfr-inhibitor-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-clustering-of-renal-cell-carcinoma-in-west-virginia-counties-with-historical-perfluorooct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-dosimetry-of-yttrium-90-radiation-segmentectomy-for-unresectable-hepatocellular-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-hematology-oncology-education-through-a-structured-ai-based-board-review-series-an-asco-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-assessment-of-polymerase-proofreading-variants-to-define-sensitivity-to-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemoimmunotherapy-followed-by-hypofractionated-radiotherapy-and-consolidation-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anamorelin-in-patients-with-non-small-cell-lung-cancer-and-cancer-cachexia-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-cancer-attribution-in-oncology-vbc-models-eampm-vs-treatment-based-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tobacco-use-driven-lung-cancer-mortality-in-the-united-states-a-population-based-analysis-from-2003 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-rechallenge-in-platinum-resistant-ovarian-cancer-evidence-from-a-propensity-score-match 2026-08-24 monthly 0.7 https://rjrindex.com/articles/explainable-ai-to-predict-molecular-classes-of-renal-cell-carcinoma-from-digital-pathology-images 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-circulating-tumor-cells-and-association-with-early-resistance-in-patients-with-metastatic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-oncologists-a-gpt-based-model-and-a-seer-based-survival-calculator-for-cancer-prognostic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-peptide-vaccine-targeting-resistance-mutations-in-advanced-alk-positive-lung-cancer-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/data-driven-precision-prognostic-stratification-in-breast-cancer-leptomeningeal-metastasis-the-bc-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iaib-trial-of-fap-dox-ava6000-a-fibroblast-activation-protein-fap-released-doxorubicin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-ireti-fusion-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-ultra-low-6-month-psa-cutoff-for-radiographic-pfs-stratification-in-high-volume-mhspc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-circulating-tumor-dna-dynamics-as-a-prognostic-and-predictive-biomarker-in-solid-tumors-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-hc-7366-with-belzutifan-in-patients-with-renal-cell-carcinoma-to-alter-tumor-and-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/center-level-delivery-patterns-and-capacity-during-rapid-car-t-expansion-in-the-united-states-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-and-prognostic-impact-of-thromboembolic-events-in-lung-cancer-patients-treated-with-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-combined-with-chemotherapy-versus-chemotherapy-alone-in-advanced-pancreatic-ductal-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-actionable-genomic-alterations-in-primary-versus-metastatic-lesions-from-chinese-lung-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-update-of-truce-01-a-phase-2-study-of-preoperative-tislelizumab-combined-with-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-immune-checkpoint-inhibitor-infusion-timing-on-overall-survival-in-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-changes-in-blood-based-immune-gene-expression-as-a-predictor-of-outcomes-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-first-in-human-fih-study-evaluating-safety-and-efficacy-of-abbv-706-results-from-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-in-iegfri-mutated-nsclc-with-refractory-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alzheimers-biomarkers-in-oncology-the-impact-of-cancer-treatment-on-neurodegenerative-diagnostic-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-exhausted-and-tolerized-myeloid-populations-in-the-glioblastoma-tumor-microenvironment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-anti-gprc5d-bispecific-therapy-versus-anti-bcma-treatment-in-relapsedrefra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-response-assessment-using-pet-rano-10-and-rano-20-in-vorasidenib-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-adoption-timing-and-survival-in-an-urban-lung-cancer-cohort-a-landmar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-multidisciplinary-therapy-combined-with-pembrolizumab-for-patients-with-synchronou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-yl201-an-anti-b7h3-antibody-drug-conjugate-adc-in-patients-with-previously-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-barriers-evaluation-of-a-low-threshold-community-based-hpv-vaccination-model-for-gender-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-to-enhance-detection-of-high-risk-minimal-residual-disease-in-ovarian-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antigen-presentation-suppression-as-a-hallmark-of-immune-evasion-and-poor-outcomes-in-small-cell-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/untreated-advanced-urothelial-carcinoma-auc-in-the-modern-treatment-era-patterns-of-care-from-a-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-of-recurrent-high-grade-gliomas-with-camrelizumab-in-combination-with-apatinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-sensitizing-pd-1pd-l1-relapsedrefractory-solid-tumors-phase-1a-results-of-ios-1002-a-lilrb12 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-tumor-repopulating-like-epithelial-cells-and-a-repair-dominant-niche-in-pathologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keynote-b59-an-open-label-multicenter-phase-12-study-of-efdelikofusp-alfa-gi-101a-cd80-igg4-fc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognitive-impairment-during-anti-egfr-targeted-therapy-in-metastatic-colorectal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-loneliness-in-glioblastoma-patients-and-caregivers-using-a-nationwide-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-systematic-review-and-pooled-analysis-of-anthracycline-versus-taxane-based-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-plasmablastic-lymphoma-according-to-immune-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-variation-in-diagnostic-and-treatment-practices-in-patients-with-her2-ebc-the-rwe-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-physical-activity-patterns-and-patient-reported-cognitive-function-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spectrum-of-germline-pathogenic-and-novel-brca1-and-brca2-gene-mutations-in-a-cohort-of-1780-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-multi-cohort-study-with-pemetrexed-plus-cisplatin-combination-in-patients-with-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-value-of-tumor-deposits-in-prognosis-evaluation-and-clinical-stage-optimization-of-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-adherence-to-adjuvant-endocrine-therapy-across-age-groups-in-hormone-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mdx-124-a-first-in-class-annexin-a1-targeting-antibody-in-patients-with-locally-advanced-or-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-erlotinib-versus-observation-after-complete-resection-of-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-combination-therapy-in-her2-positive-metastatic-breast-cancer-mbc-first-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-adapted-step-up-local-therapy-for-malignant-portal-vein-tumor-thrombus-from-hepatic-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-cdx-1140-a-cd40-agonist-in-combination-with-capecitabine-and-oxaliplatin-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erbb-family-members-as-mediators-of-acquired-resistance-to-immunotherapy-in-high-grade-serous-ovaria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-structured-oncologist-led-home-visits-on-psychological-distress-and-resilience-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-recurrence-and-risk-factors-in-resectable-early-stage-adenocarcinoma-with-uncommon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-new-prostate-cancer-risk-groups-by-psma-pet-ppp3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-low-muscle-mass-assessed-by-bioelectrical-impedance-analysis-and-clinical-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comfort-survey-a-comparison-of-the-comfort-level-of-hematologic-and-solid-tumor-oncology-specialist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consumer-wearables-and-medical-care-utilization-in-gastrointestinal-cancers-a-fitbit-data-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-characteristics-in-patients-with-hormone-receptor-positive-hr-her2-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-hlx07-vs-placebo-combined-with-serplulimab-and-chemotherapy-for-nasopharyngeal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-ipatasertib-in-combination-with-pembrolizumab-for-first-line-treatment-of-recurre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elacestrant-in-combination-with-capivasertib-in-patients-with-erher2-advanced-breast-cancer-upda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-access-to-retinoblastoma-care-geographic-disparities-and-service-availability-across-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-third-line-treatments-in-metastatic-colorectal-cancer-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-of-trifluridine-tipiracil-with-or-without-bevacizumab-in-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-in-hematologic-malignancies-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-and-associated-clinical-outcomes-in-cancer-patients-treated-with-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metformin-use-and-outcomes-among-breast-cancer-patients-on-immunotherapy-insights-from-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-biomarker-testing-rates-targeted-therapy-use-and-clinical-outcomes-in-patients-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-antibody-drug-conjugates-and-targeted-therapies-in-acute-myeloid-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-efficacy-of-hereditary-cancer-didactic-training-program-for-advanced-practice-provider 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerate-tobacco-treatment-in-cancer-care-with-evidence-based-implementation-strategies-how-to-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mid-treatment-circulating-tumor-hpv-dna-to-guide-early-radiotherapy-cessation-in-hpv-associated-orop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-cancer-outcomes-through-equity-interventions-tailored-for-hispanic-families 2026-08-24 monthly 0.7 https://rjrindex.com/articles/golcadomide-golca-a-potential-first-in-class-oral-celmod-rituximab-r-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facility-level-differences-in-treatment-patterns-and-outcomes-among-patients-aged-75-years-with-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/staging-surgery-and-relapse-patterns-in-uterine-sarcomas-a-single-institution-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/winship-4468-18-phase-ii-evaluation-of-the-effect-of-2-versus-6-hour-oxaliplatin-infusions-on-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-liver-cancer-incidence-in-the-united-states-1999-2022-a-joinpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiotoxicity-and-mortality-trends-in-chemotherapy-treated-breast-cancer-patients-before-and-during 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-evaluation-of-immune-checkpoint-inhibitors-in-soft-tissue-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-soft-tissue-sarcoma-of-the-heart-in-the-united-states-1975-2022-a-seer-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-board-based-multi-agent-llms-with-guideline-retrieval-and-consensus-deliberation-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-expenditure-of-cardioprotective-drugs-in-cancer-survivors-medical-expenditure-panel-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinicopathologic-features-and-outcomes-of-gastric-esophageal-and-gastroesophageal-junc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-context-matters-knowledge-distillation-enabled-resnet-modeling-for-noninvasive-stratificatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-strategies-and-survival-outcomes-in-hepatic-epithelioid-hemangioendothelioma-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/declined-or-refused-electronic-health-record-documentation-of-patients-who-do-not-proceed-with-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-demographic-reporting-in-clinical-trials-supporting-nccn-nsclc-guidelines 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-embolization-plus-hepatic-arterial-infusion-chemotherapy-combined-with-rivoceranib-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ide892-as-monotherapy-and-in-combination-with-ide397-in-patients-with-5-methylthioadenosine-phosphor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-survival-and-prognostic-factors-among-patients-with-mycosis-fungoides-and-seza 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-fih-dose-escalation-and-dose-optimization-study-to-evaluate-the-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-conversion-surgery-survival-outcomes-and-safety-of-atezolizumab-plus-bevacizumab-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dexrazoxane-for-anthracycline-cardiotoxicity-prevention-in-pediatric-and-aya-cancers-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-factors-and-screening-practices-in-global-lung-cancer-staging-disparities-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-recovery-after-surgery-in-major-oncologic-head-and-neck-surgery-a-systematic-review-and-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institutional-epidemiologic-and-oncologic-profile-of-gastrointestinal-stromal-tumors-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-pd-1-inhibitor-tislelizumab-combined-with-chemotherapy-for-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-access-gap-first-line-blinatumumab-for-kmt2a-rearranged-infant-acute-lymphoblastic-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-combined-with-5-fulv-and-bevacizumab-as-second-line-therapy-for-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-demographic-trends-in-mortality-from-multiple-myeloma-with-coexisting-mental-and-behavi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-genomic-rearrangements-in-germline-ibrca12i-path 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-droplet-digital-pcr-test-for-monitoring-esr1-ctdna-variants-in-blood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-treatment-journey-following-antibody-drug-conjugate-adc-initiation-sequencing-pattern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-inherited-cancer-care-and-its-impact-in-a-rural-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytisinicline-for-smoking-cessation-among-patients-with-a-history-of-cancer-a-post-hoc-analysis-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inotuzumab-ozogamicin-versus-blinatumomab-in-pediatric-relapsedrefractory-cd22-positive-b-cell-acut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-specific-risks-of-leukemia-in-li-fraumeni-syndrome-in-children-adolescents-young-adults-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-germline-ibrca12i-variants-on-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-hypertension-associated-mortality-among-patients-with-lung-cancer-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-versus-benefit-a-prospective-matched-analysis-of-sbrt-with-vs-without-adt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-patient-reported-outcomes-measurement-information-system-promis-utilization-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-cardiovascular-kidney-and-metabolic-disease-in-breast-and-lung-cancer-patients-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-systemic-delays-in-targeted-therapy-tt-access-for-advanced-nsclc-ancslc-with-actionabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-multi-center-study-of-kivu-107-a-novel-ptk7-targeting-antibody-drug-conjugate-adc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dedicated-multidisciplinary-oligometastatic-breast-cancer-clinic-ombcc-as-a-platform-for-standardi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-diagnostic-delay-signature-in-rare-gynecologic-cancers-assessment-of-emergency-presentation-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-in-patients-with-iegfri-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-national-mortality-patterns-in-intrahepatic-versus-extrahepatic-cholangiocarcinoma-a-popul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-atlas-study-a-first-in-human-phase-12-trial-of-ac-225rtx-2358-in-patients-with-relapsed-or-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-non-hodgkin-lymphoma-in-sarcoidosis-patients-with-salivary-gland-involvement-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-donafenib-combined-with-tace-and-withwithout-pd-l1-inhibitors-for-unresect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-typical-and-atypical-lung-neuroendocrine-tumors-in-a-rural-us-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-single-arm-study-of-lirafugratinib-in-patients-with-previously-treated-unres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-app-led-intake-model-to-expedite-diagnostic-workup-for-patients-with-suspected-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lineage-specific-outcomes-and-resource-utilization-associated-with-antiphospholipid-syndrome-and-thr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-artery-infusion-chemotherapy-plus-adebrelimab-and-bevacizumab-as-first-line-treatment-for-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-open-label-dose-escalation-study-of-car001-mrna-engineered-nb-carbite-ghd-t-cells-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tidal-a-phase-ii-study-of-the-dll3-directed-t-cell-engager-tarlatamab-in-dll3-positive-metastatic-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-1-study-of-dcc-2812-monotherapy-in-patients-with-advanced-genitourinary-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-piflufolastat-f-18-and-imaging-associated-treatment-patterns-in-early-stage-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acceptability-of-a-narrative-video-intervention-to-promote-clinical-trial-decision-making-among-blac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inflammatory-markers-as-predictors-of-pathological-complete-response-in-patients-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pain-response-with-stereotactic-body-radiation-therapy-versus-conventional-external-beam-radiotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-hypomagnesemia-and-pertuzumab-discontinuation-in-her2-positive-breast-cancer-a-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pd-1pd-l1-inhibitors-combined-with-chemotherapy-in-early-stage-triple-negative-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subtype-specific-melatonin-receptor-expression-on-circulating-tumor-cells-and-associated-inflammator 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-genomic-and-transcriptomic-profiling-of-a-breast-cancer-cohort-in-the-uae-compared-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-incidence-and-severity-of-neurotoxicity-with-six-fda-approved-chimeric-receptor-t-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iugt1a1i-gene-variants-associated-with-irinotecan-toxicity-in-patients-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-oral-serd-plus-cdk46-inhibitors-in-recurrent-or-metastatic-erher2-breast-cancer-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-baveno-vii-criteria-for-endoscopy-risk-stratification-prior-to-systemic-therapy-in-unrese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-breast-cancer-central-nervous-system-metastases-treated-with-sacituzumab-govi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-peripheral-immune-response-induced-by-multimodal-thermal-therapy-combined-with-chemoimm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sglt2i-and-glp1-agonists-on-prostate-cancer-incidence-and-outcomes-a-real-world-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concurrent-tissue-tbx-and-liquid-lbx-based-comprehensive-genomic-profiling-cgp-on-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racialethnic-and-age-related-disparities-in-contralateral-breast-cancer-risk-among-survivors-seer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-receptor-agonist-use-with-mortality-and-hospitalization-in-women-with-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-clinical-trial-on-intratumoral-autologous-cd1c-bdca-1-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-checkpoint-inhibitor-administration-timing-with-toxicity-and-survival-in-uteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-ctdna-detection-at-the-time-of-relapse-during-melanoma-surveillance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-visceral-disease-burden-and-treatment-delivery-factors-association-with-outcomes-after-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-mortality-among-patients-with-mental-and-behavioral-disorders-in-the-united-states-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-immune-checkpoint-inhibitors-in-soft-tissue-sarcoma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-gastric-cancer-mortality-in-south-asia-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-infectious-workup-and-antibiotic-use-during-tarlatamab-initiation-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-mitochondrial-free-radical-markers-in-endometrioid-adenocarcinoma-and-an-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/partial-versus-radical-nephrectomy-for-renal-cell-carcinoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recon-a-trainee-led-needs-informed-professional-development-and-global-connectivity-model-for-youn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-bren-bl-m07d1-in-patients-with-recurrent-or-metastatic-rm-ovarian-cancer-results-from-two-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-in-malignant-thymic-neoplasms-a-comprehensive-real-world-analysis-from-a-brazili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-methylation-based-liquid-biopsy-for-longitudinal-monitoring-of-treatment-response-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-placebo-controlled-pilot-study-of-add-on-beta-sitosterol-supplementation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cld-401-a-next-generation-systemic-gene-therapy-for-tumor-localized-expression-of-il-15-superagonis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-kidney-sparing-approach-using-disitamab-vedotin-plus-toripalimab-for-high-risk-upper-urinary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-virtual-transcriptome-screening-to-identify-repurposable-combination-partners-for-jin-a02 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-study-of-selinexor-added-to-standard-induction-and-consolidation-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-first-in-human-study-of-yttrium-90-carbon-microspheres-in-patients-with-unresectable-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-multi-cancer-early-detection-mced-assay-independent-blinded-validation-of-a-locke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effective-colorectal-cancer-screening-in-the-united-states-comparative-analyses-of-four-molecu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-fdg-pet-based-bone-marrow-assessment-on-prognostic-accuracy-compared-to-conventional-histo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guard-01-a-randomized-open-label-trial-of-efbemalenograstim-alfa-as-primary-prophylaxis-for-neutro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-and-efficacy-characterization-of-doxorubicin-and-trabectedin-association-versus-doxorubicin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-clonal-hematopoiesis-driven-by-mosaic-chromosomal-alterations-with-epigenetic-age-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-teclistamab-plus-daratumumab-in-relapsed-or-refractory-multiple-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-hematotoxicity-using-ct-derived-body-composition-in-rectal-cancer-patients-receiving-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-variant-topography-of-inpm1i-mutations-in-acu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tinengotinib-tt-00420-in-advancedmetastatic-fgfr2-altered-cholangiocarcinoma-following-prior-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-an-ongoing-phase-1-study-of-lb2102-a-dntgfbr2-armored-dll3-targeted-autolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmet-rehabilitation-needs-in-cancer-survivors-a-population-level-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-with-neoadjuvant-chemoimmunotherapy-in-clinical-stage-ii-iii-nsclc-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-of-therapy-related-myeloid-neoplasms-in-parp-inhibitor-treated-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-challenges-in-the-adoption-of-emerging-therapies-for-extensive-stage-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-immune-cell-subsets-and-intestinal-flora-in-immune-related-adverse-event-of-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-and-molecular-features-of-krukenberg-tumors-from-gastric-cancer-gc-a-single-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-neoadjuvant-chemotherapy-in-both-the-breast-and-lymph-nodes-in-patients-with-inflammator 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dce-mri-for-assessment-of-pathologic-complete-response-after-completion-of-neoadjuvant-therapy-in-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-ischemic-stroke-and-ischemic-heart-disease-related-mortality-among-patients-with-malignanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-racial-disparities-in-pulmonary-embolism-related-mortality-among-older-adults-with-neopla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-olaparib-plus-atr-inhibitor-ceralasertib-in-patients-with-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iiia-study-of-dn022150-a-novel-selective-noncovalent-small-molecule-kras-g12d-inhibitor-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-systemic-chemotherapy-combined-with-camrelizumab-cam-and-apatinib-apa-for-bclc-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-we-call-every-cancer-a-rare-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-money-cannot-buy-addressing-the-socioeconomic-status-ceiling-effect-for-black-patients-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diminishing-returns-among-black-patients-with-cancer-the-intersection-of-race-and-neighborhood-soci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-immune-checkpoint-blockade-in-deficient-mismatch-repairmicrosatellite-instability-high-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-it-time-to-move-beyond-graft-versus-host-disease-free-relapse-free-survival-as-a-primary-end-poi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-chemoradiotherapy-in-esophageal-adenocarcinoma-matters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-for-minimal-residual-disease-in-colon-cancer-ready-for-prime-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-blockade-in-deficient-mismatch-repairmicrosatellite-instability-high-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-size-and-bladder-cancer-risk-a-pooled-analysis-of-prospective-studies-from-the-national-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iiiii-trial-comparing-hepatectomy-followed-by-mfolfox6-with-hepatectomy-alone-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-quality-of-chemoradiotherapy-in-esophageal-adenocarcinoma-matters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tissue-free-circulating-tumor-dna-assay-and-patient-outcome-in-a-phase-iii-trial-of-folfox-based-adj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-hepatic-arterial-infusion-with-oxaliplatin-after-surgery-of-four-or-more-colorectal-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selpercatinib-and-the-crossover-conundrum-potential-impact-of-postprogression-therapies-on-overall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addition-of-metastasis-directed-therapy-to-standard-of-care-for-oligometastatic-disease-primary-agg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/balancing-risk-benefit-and-reality-navigating-early-phase-studies-in-pediatric-diffuse-midline-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-phase-i-trial-of-gd2cart-cells-augmented-with-constitutive-interleukin-7-receptor-for-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-pathologic-response-evaluation-and-detection-in-circulating-tumor-dna-study-ultrasensitive-circ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-prognosis-to-action-circulating-tumor-dna-and-the-next-phase-of-risk-stratification-in-triple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-parametric-assumptions-unsupervised-methods-enhance-dna-repair-gene-discovery-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medicaid-expansion-and-stage-at-diagnosis-timely-initiation-and-receipt-of-guideline-concordant-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methodologic-considerations-for-subsequent-colorectal-cancer-in-survivors-of-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-medicaid-policy-and-implications-for-high-quality-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-tissue-free-circulating-tumor-dna-assay-and-patient-outcome-in-a-phase-iii-trial-of-folfox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-il15-activated-cytokine-induced-killer-cells-after-allogeneic-hct-shows-dura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-methodologic-considerations-for-subsequent-colorectal-cancer-in-survivors-of-childhood-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-beyond-parametric-assumptions-unsupervised-methods-enhance-dna-repair-gene-discovery-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-unmutated-igg1-a-wrong-choice-for-therapeutic-antibodies-targeting-immune-checkpoints-lessons-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-treatment-of-thyroid-cancer-asco-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-mosperafenib-a-novel-paradox-breaker-b-raf-proto-oncogene-serinethreonine-kinase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ending-the-controversy-around-pretreatment-dihydropyrimidine-dehydrogenase-dpd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-from-thresholds-to-tumor-sidedness-reframing-human-epidermal-growth-factor-receptor-2-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-genetic-information-and-family-testing-study-a-cluster-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-brain-barrier-heterogeneity-in-nrg-bn007-implications-for-immunotherapy-delivery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fullerene-for-reducing-acute-radiation-dermatitis-in-patients-undergoing-radiotherapy-for-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dear-doctor-we-still-have-no-idea-of-what-dose-of-capecitabine-you-should-prescribe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/residual-absolute-volume-of-blastema-as-a-predictor-of-clinical-outcomes-in-patients-with-wilms-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/old-dog-new-tricks-oxybutynin-for-the-treatment-of-androgen-deprivation-therapy-related-vasomotor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-rezetecan-in-human-epidermal-growth-factor-receptor-2-expressing-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-efficacy-and-safety-data-from-the-phase-iii-arrow-study-of-pralsetinib-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a222001-oxybutynin-versus-placebo-for-the-treatment-of-hot-flashes-in-patients-receiving-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-blood-brain-barrier-heterogeneity-in-nrg-bn007-implications-for-immunotherapy-delivery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-thresholds-to-tumor-sidedness-reframing-human-epidermal-growth-factor-receptor-2-in-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-design-and-objectives-for-patients-with-prostate-cancer-recommendations-from-the-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-much-is-enough-ultra-low-doses-of-immunotherapy-to-improve-access-and-affordability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-limitations-in-study-design-and-stratification-in-phase-ii-stereotactic-radiosurgery-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-and-targeted-therapy-for-advanced-gastroesophageal-cancer-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/good-oncologist-doctoring-lessons-from-the-art-of-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-the-system-is-the-treatment-rethinking-nonpharmacologic-breakthroughs-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limitations-in-study-design-and-stratification-in-phase-ii-stereotactic-radiosurgery-trial-for-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/calypso-final-results-of-savolitinib-and-durvalumab-combination-in-metastatic-papillary-renal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/target-trial-emulation-for-regulatory-and-clinical-decision-making-in-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-what-we-can-learn-from-leap-010-in-recurrentmetastatic-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiosurgery-for-small-cell-lung-cancer-brain-metastases-comparing-the-jlgk0901-and-bwhdfci-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-hardship-before-diagnosis-influence-on-late-stage-cancer-presentation-and-the-role-of-scr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ultra-low-dose-immunotherapy-in-relapsed-refractory-solid-tumors-phase-iii-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-ipilimumab-in-patients-with-pretreated-advanced-neuroendocrine-carcinoma-the-gco-001-ni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-with-or-without-lenvatinib-as-first-line-therapy-for-recurrent-or-metastatic-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/viktoria-1-trial-of-gedatolisib-plus-fulvestrant-with-or-without-palbociclib-in-hormone-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-indications-for-stereotactic-radiosurgery-in-small-cell-lung-cancer-with-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-classifier-for-metabolic-subtypes-of-nasopharyngeal-carcinoma-to-guide-personalized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disruptive-analysis-of-total-neoadjuvant-therapy-in-locally-advanced-rectal-cancer-clinical-and-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-haploidentical-donor-selection-for-pediatric-hematopoietic-cell-transplant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-oncology-20-guiding-magic-bullets-with-expression-based-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-bcma-chimeric-antigen-receptor-t-cell-therapy-in-patients-with-newly-diagnosed-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-clinician-communication-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-and-immunotherapy-another-good-marriage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mifamurtide-in-nonmetastatic-high-grade-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-combined-with-camrelizumab-and-rivoceranib-for-unresectable-hepatoce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thanksgiving-still 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-with-capox-versus-chemoradiation-for-locally-advanced-rectal-cancer-with-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-mammographic-screening-among-a-large-population-of-underserved-subgroups 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response-in-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-and-safety-of-selumetinib-granule-formulation-in-children-with-symptomatic-inopera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-friendly-formulations-critical-to-maximizing-benefit-of-novel-therapeutics-such-as-selume 2026-08-24 monthly 0.7 https://rjrindex.com/articles/izalontamab-brengitecan-in-locally-advanced-or-metastatic-non-small-cell-lung-cancer-with-actionable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-focal-boosting-in-localized-prostate-cancer-in-the-era-of-systemic-therapy-and-prostate-sp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-therapy-related-malignancy-and-the-risk-of-cancer-exceptionalism 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incremental-progress-in-the-cervical-cancer-screening-revolution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pivekimab-sunirine-in-blastic-plasmacytoid-dendritic-cell-neoplasm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-multiple-myeloma-asco-ontario-health-cancer-care-ontario-living-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quiet-work-of-clarity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-or-without-risk-reducing-mastectomy-in-ibrca1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-breast-cancer-after-ovarian-cancer-in-women-with-a-pathogeniclikely-pathogenic-variant-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/focal-boosting-in-localized-prostate-cancer-in-the-era-of-systemic-therapy-and-prostate-specific-mem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-prospective-cohort-study-of-cervical-cancer-screening-using-triage-of-women-who-are-human 2026-08-24 monthly 0.7 https://rjrindex.com/articles/past-present-and-future-of-dexamethasone-in-multiple-myeloma-and-al-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacodynamics-of-camizestrant-treatment-in-postmenopausal-women-with-estrogen-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wbc-growth-factors-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-heavy-alcohol-use-associated-with-young-onset-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-clinical-outcomes-with-nivolumab-plus-ipilimumab-versus-chemotherapy-as-first-line-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/threshold-dose-response-association-between-alcohol-consumption-and-risk-of-young-onset-pancreatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/windows-of-opportunity-in-breast-cancer-learning-more-from-fewer-patients-in-a-shorter-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-circulating-tumor-dna-and-copy-number-alterations-on-clinical-outcome-in-relapsedrefracto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-induction-nivolumab-before-chemoradiation-in-intermediatehigh-risk-human-papillom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-power-of-i-dont-know 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-can-pathologic-complete-response-serve-as-a-valid-surrogate-end-point 2026-08-24 monthly 0.7 https://rjrindex.com/articles/axitinib-and-long-acting-octreotide-in-advanced-extrapancreatic-neuroendocrine-tumors-a-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-nivolumab-before-chemoradiation-in-high-risk-human-papillomavirus-driven-oropharynx-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-it-time-to-retire-the-unified-cancer-of-unknown-primary-concept-in-the-precision-oncology-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-pathologic-complete-response-serve-as-a-valid-surrogate-end-point 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-is-of-the-essence-sequencing-immune-checkpoint-blockade-and-radiotherapy-for-success-in-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erdafitinib-or-erdafitinib-plus-cetrelimab-for-patients-with-metastatic-urothelial-carcinoma-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboembolic-events-during-perioperative-therapy-for-resectable-and-borderline-resectable-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survivorship-after-chimeric-antigen-receptor-t-cell-therapy-for-hematologic-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-efficacy-and-biomarker-study-of-bevacizumab-for-hearing-loss-resulting-from-neurofibromatos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-enhancing-representation-and-reporting-of-body-mass-index-in-cancer-randomized-clinical-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethics-of-backfilling-in-early-phase-oncology-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-br31-trial-adjuvant-durvalumab-as-the-third-contender-in-resected-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stellar-phase-iii-randomized-open-label-study-of-eflornithine-plus-lomustine-versus-lomustine-alo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tbcrc-048-olaparib-expanded-expansion-cohorts-phase-ii-study-of-olaparib-monotherapy-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-molecular-diagnosis-paving-the-way-for-therapeutic-success-in-recurrent-astrocytoma-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-rise-and-fall-of-neoadjuvant-carboplatin-for-human-epidermal-growth-factor-receptor-2-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-representation-and-reporting-of-body-mass-index-in-cancer-randomized-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoradiation-atezolizumab-in-limited-stage-small-cell-lung-cancer-results-of-nrg-oncologyallia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-electronic-patient-reported-outcomes-and-palliative-care-in-pediatric-advanced-cancer-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-consensus-driven-recommendations-for-patient-reported-outcome-research-objectives-in-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-drug-development-challenges-of-increasingly-available-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-study-of-adebrelimab-and-bevacizumab-combined-with-cisplatincarboplatin-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-clinical-results-and-associated-biomarkers-from-an-ongoing-phase-1-study-of-fx-909-a-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s1823cctg-gcc-01-secondary-use-of-data-north-american-patterns-of-care-in-clinical-stage-i-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-clinicopathological-features-and-prognoses-of-de-novo-metastatic-male-and-female-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-after-first-line-chemotherapy-with-normal-serum-tumor-markers-stm-in-non-seminomatous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-kim-1-and-ctdna-as-prognostic-markers-in-oligometastatic-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imges-study-a-prospective-multicentre-phase-ii-trial-of-sequential-intravesical-mitomycin-c-and-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assistance-of-a-large-language-model-based-ai-agent-in-preoperative-communication-for-reduction-of-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-dna-damage-repair-ddr-pathway-class-and-allelic-configuration-with-survival-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-high-grade-prostate-cancer-at-diagnosis-in-the-united-states-from-2004-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/salvage-radiotherapy-after-radical-prostatectomy-in-a-japanese-cohort-analysis-from-the-mican-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-bladder-cancer-and-comorbid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-rezvilutamide-in-preventing-the-flare-phenomenon-induced-by-gnrh-agonists-in-newly-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-coverage-whole-genome-sequencing-of-urinary-tumor-dna-to-characterize-genomic-correlates-of-lymp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-hidden-burden-of-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-keymaker-u03-substudy-03c-of-belzutifan-plus-zanzalintinib-or-belzutifan-monotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-monitoring-of-self-reported-symptoms-by-patients-treated-with-cabozantinib-plus-nivolumab-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-physician-preferences-for-treatment-in-advanced-renal-cell-carcinoma-pear-an-internat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-cabozantinib-in-relapsed-refractory-germ-cell-tumors-gct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-delivery-of-prostate-cancer-germline-testing-at-the-department-of-veterans-affairs-a-clus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benign-persistent-elevation-of-alphafoetoprotein-afp-after-curative-treatment-for-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-os-improvements-in-metastatic-urothelial-carcinoma-muc-across-three 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-risk-localized-prostate-cancer-treated-with-neoadjuvant-lhrh-agonistantagonist-and-enzalutamid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-role-of-pd-l1-in-penile-squamous-cell-carcinoma-a-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-interruption-guided-by-on-treatment-prostate-specific-membrane-antigen-psma-petct-imagi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fifteen-year-survival-analysis-from-the-ascende-rt-randomized-trial-of-external-beam-boost-versus-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-genomic-profiling-and-circulating-tumor-dna-monitoring-to-optimize-surveillance-strategi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relapsedrefractory-clinically-advanced-ca-testicular-non-seminomatous-germ-cell-tumors-nsgct-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-darolutamide-to-enhance-prostate-specific-membrane-antigen-expression-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-3v-hsd1-on-back-conversion-and-androgen-signaling-in-crpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-ev-related-cutaneous-toxicity-to-predict-metabolic-response-on-fluorodeoxygluco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-a-diet-high-in-omega-3-polyunsaturated-fatty-acids-pufas-on-inhibition-of-soluble-epoxi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-quantitative-functional-rad51-foci-and-genomic-alterations-in-predicting-parpi-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lenvatinib-plus-pembrolizumab-in-patients-with-advanced-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/network-meta-analysis-of-second-and-later-line-therapies-in-advanced-renal-cell-carcinoma-a-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-innovation-to-evidence-trends-in-aiml-clinical-trials-in-gu-oncology-2010-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-urinary-diversion-type-influence-long-term-renal-outcomes-after-radical-cystectomy-a-multicent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-of-disease-recurrence-and-outcomes-of-localized-high-risk-renal-cell-carcinoma-rcc-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-selective-renal-tumor-embolization-combined-with-axitinib-and-reduced-dose-toripalimab-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-therapeutic-efficacy-of-radical-prostatectomy-and-external-beam-radiation-therapy-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-upfront-dose-reductions-on-efficacy-of-enfortumab-vedotin-and-pembrolizumab-evp-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcomes-with-iclostridium-butyricumi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-belzutifan-in-participants-from-china-and-japan-with-von-hippel-lindau-disease-asso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-climate-a-prospective-cohort-study-assessing-the-clinical-utility-of-mir-371a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-as-a-real-time-biomarker-in-marker-negative-germ-cell-tumors-gct-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-double-blind-placebo-controlled-study-of-adjuvant-saruparib-azd5305-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/saruparib-androgen-receptor-pathway-inhibitor-arpi-androgen-deprivation-therapy-adt-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-diversity-and-clinical-relevance-of-germline-dna-damage-repair-gene-variants-in-3005-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-psa-decline-patterns-in-the-chinese-subgroup-of-libertas-a-phase-3-study-of-apalutami 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomised-multicentre-phase-ii-trial-of-active-surveillance-with-or-without-six-months-of-apalu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protact-a-first-in-human-phase-1-dose-escalation-and-expansion-study-evaluating-the-safety-tolera-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-investigator-initiated-enterprise-divine-in-prostate-cancer-randomized-phase-ii-trial-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surveillance-after-complete-response-cr-to-first-line-chemotherapy-chemo-in-non-seminomatous-ger 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-socioeconomic-disparities-in-early-onset-vs-late-onset-bladder-cancer-a-cross-sect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-variant-histology-bladder-cancer-insights-from-seer-2000-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-pharmacists-into-uro-oncology-care-evaluation-of-patient-satisfaction-and-well-being 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-trial-and-practice-real-world-data-of-adjuvant-nivolumab-in-high-risk-muscle-invasive-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-overlooked-culprit-tumor-size-in-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-early-circulating-tumor-dna-ctdna-response-in-advanced-urothelial-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-comparison-of-ar-v7-transcripts-from-whole-blood-and-circulating-tumor-cells-in-castrati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-sup177sup-lulu-psma-617 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-relationship-between-vasculitis-and-metastasis-in-kidney-related-urogenital-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iparp1i-and-ibrca12i-expressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-trial-of-neoadjuvant-sasanlimab-and-stereotactic-body-radiation-therapy-as-an-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-post-hifu-surveillance-diagnostic-performance-of-18f-psma-petct-and-mpmri-for-local-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fixed-low-dose-nab-paclitaxel-with-tislelizumab-in-non-metastatic-bladder-cancer-a-post-hoc-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-prediction-of-psa-nadir-in-metastatic-castration-sensitive-prostate-cancer-with-machine-learni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-renal-cell-carcinoma-with-sarcomatoid-differentiation-treated-with-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-demographic-disparities-in-prostate-cancer-patients-undergoing-radical-prostatectomy-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pro-from-a-dose-escalation-and-expansion-trial-of-fractionated-and-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-method-of-analysis-that-uses-standard-of-care-psa-values-to-help-guide-optimal-treatment-dec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-prostate-specific-antigen-response-and-overall-survival-in-metastatic-hormone-sensitive-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-urothelial-carcinoma-with-squamous-differentiation-with-nectin-4-expression-and-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-in-pretreated-patients-pts-with-her2-expressing-bladder-cancer-fin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemcitabine-intravesical-system-plus-cetrelimab-or-cetrelimab-alone-as-neoadjuvant-therapy-in-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-pembrolizumab-plus-belzutifan-versus-pembrolizumab-for-clear-cell-renal-cell-carcinoma-ccr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-targeted-biopsy-with-index-lesion-ipsilateral-or-bilateral-systematic-biopsy-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lunar-safety-and-efficacy-evaluation-of-nadofaragene-firadenovec-instilled-into-the-renal-pelvis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/any-regression-of-tumor-art-to-discriminate-improvement-in-overall-survival-os-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cell-detection-and-prognostic-relevance-in-patients-with-metastatic-genitourinary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-of-prostate-specific-antigen-psa-flare-and-response-dynamics-in-talapro-2-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiometabolic-healths-influence-on-outcomes-in-men-with-localized-high-risk-prostate-cancer-hrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nezastomig-anti-psmacd28-with-or-without-cemiplimab-anti-pd-1-in-patients-with-metastatic-castr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-and-effectiveness-of-first-line-enfortumab-vedotin-ev-with-pembrolizumab-p-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-radium-223-in-the-frontier-study-impact-of-prior-up-front-therapy-in-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-chemotherapy-on-perioperative-outcomes-following-nephroureterectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-access-to-clinical-trial-participation-among-underrepresented-kidney-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-novel-hormonal-therapies-in-european-and-north-american-patients-pts-with-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-monitoring-of-biochemically-recurrent-prostate-cancer-bcr-using-prostate-specific-memb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fgfr-altered-metastatic-urothelial-carcinoma-in-the-real-world-setting-insight-from-the-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-amyloid-a4-and-cognitive-functioning-in-long-term-testicular-germ-cell-tumor-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-remodeling-of-urine-exposed-ileal-mucosa-after-ileocystoplasty 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-design-and-objectives-for-prostate-cancer-recommendations-from-the-prostate-cancer-clinical-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/membranous-nectin-4-expression-to-predict-enfortumab-vedotin-response-in-metastatic-urothelial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-preoperative-glycemic-control-and-outcomes-after-radical-prostatectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-in-elderly-frail-or-high-comorbidity-veterans-receiving-androgen-receptor-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-darolutamide-safety-and-effectiveness-in-nonmetastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-vs-switch-maintenance-checkpoint-inhibition-in-urothelial-carcinoma-a-systematic-review-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-predictors-of-primary-retroperitoneal-lymph-node-dissection-p-rplnd-vs-primary-chemot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-combined-with-everolimus-in-chinese-patients-with-advancedmetastatic-clear-cell-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biopsy-patterns-following-high-intensity-focused-ultrasound-as-assessed-by-capra-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-the-real-world-utilization-of-177lu-psma-617-in-metastatic-castrate-resistant-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discontinuation-rates-among-patients-with-metastatic-castration-sensitive-prostate-cancer-mcspc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-clinico-genomic-characterization-reveal-more-aggressive-prostate-cancer-among-older-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-hot-flashes-on-sleep-metrics-during-initial-treatment-in-libertas-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-mutational-burden-to-predict-overall-survival-independent-of-tp53-status-in-tcga-bladder-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-renal-function-in-non-hydronephrotic-patients-receiving-pd-1-icis-for-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-sacituzumab-govitecan-sg-plus-pembrolizumab-pembro-followed-by-response-adapted-bla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-with-second-line-2l-therapies-in-patients-pts-with-advanced-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspire-gct-a-single-arm-phase-ii-clinical-trial-of-aspirin-to-prevent-venous-thromboembolism-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiographic-recurrence-patterns-for-prostate-cancer-with-pathologic-lymph-node-involvement-followin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-detection-of-treatment-emergent-metastatic-neuroendocrine-carcinoma-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ierbb3i-altered-clinically-advanced-urothelial-bladder-cancer-genomic-lan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-based-detection-of-mtap-gene-loss-in-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resq133a-nmibc-a-phase-12-clinical-trial-of-intravesical-recombinant-mycobacterium-bacillus-calmet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-treatment-responses-to-enfortumab-vedotin-combined-with-pembrolizumab-evp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-to-guide-response-adapted-bladder-preservation-in-muscle-invasive-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-time-to-next-treatment-in-metastatic-urothelial-cancer-patients-enfortumab-vedotin-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-genomic-prognostic-and-hallmark-signatures-from-decipher-grid-to-predict-adverse-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-patients-pts-with-synchronous-vs-metachronous-metastatic-or-locally-advanced-urotheli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-of-therapeutic-agents-before-and-after-metastatic-castration-resistant-prostate-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/skeletal-muscle-index-as-a-prognostic-and-predictive-biomarker-in-de-novo-hormone-sensitive-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-lenvatinib-plus-pembrolizumab-with-or-without-stereotactic-body-radiot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomics-approach-for-patient-stratification-and-novel-target-identification-in-metastatic-clear-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-us-community-based-evaluation-of-recurrence-among-non-muscle-invasive-bladder-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-association-to-identify-snps-associated-with-severe-adverse-events-and-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-serplulimab-as-first-line-therapy-in-metastatic-or-unresectable-non-clear-cell-ren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rescuing-cancer-immunotherapy-with-plasma-exchange-in-bladder-cancer-1-recipe-b1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-a-digital-pathology-based-multimodal-artificial-intelligence-mmai-derived-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inherited-risk-for-prostate-cancer-pca-following-the-natural-history-of-men-with-increased-geneti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-nivolumab-plus-cabozantinib-in-metastatic-renal-cell-carcinoma-mrcc-using-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-rules-based-ai-triage-system-to-identify-nccn-indicated-genetic-testing-in-prostate-cancer-a-perf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-cancer-causes-of-death-in-patients-with-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatially-resolved-her2-and-ar-expression-in-prostate-cancer-and-its-implications-for-her2-as-a-dist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-urinary-exosomal-fam153c-rpl19-in-detection-and-risk-stratification-of-prostate-cancer-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effects-of-sodium-glucose-cotransporter-2-inhibitor-use-on-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-management-and-multidisciplinary-care-in-highvery-high-and-intermediate-risk-localized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-treatment-burden-of-bcg-versus-sequential-gemcitabine-and-docetaxel-for-non-muscle-invas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-pembrolizumab-in-non-clear-cell-renal-cell-carcinoma-after-nephrectomy-an-international-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sppade-symptom-burden-and-epro-based-outcome-prediction-in-patients-with-mcrpc-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-transitions-and-healthcare-resource-utilization-in-patients-with-metastatic-cas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carboplatin-in-patients-with-metastatic-castration-resistant-prostate-cancer-harboring-somatic-or-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opportunities-for-precision-oncology-real-world-patterns-and-disparities-in-fgfr3-testing-among-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ideate-prostate01-a-phase-3-randomized-open-label-study-of-ifinatamab-deruxtecan-versus-docetaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup177sup-lulu-psma-617-sup1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-global-gaps-expanding-gu-oncology-education-through-iecho-telementoring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/four-year-outcomes-of-a-genetic-based-screening-protocol-for-prostate-cancer-unveiling-the-italian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-muscle-quantity-to-predict-acute-kidney-injury-after-radical-cystectomy-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aligning-goals-of-care-at-the-time-of-treatment-planning-with-the-abc123-framework-a-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-tumor-methionine-metabolism-via-mat2a-on-cd8-t-cell-exhaustion-through-sam-chop-axis-in-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pro-and-tolerability-of-capivasertib-capi-plus-abiraterone-abi-versu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hcrn-gu22-598-phase-2-trial-of-enfortumab-vedotin-plus-pembrolizumab-with-selective-bladder-sparing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-combination-sup177sup-lu-girentuxim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-ct-radiomics-deep-learning-signature-for-lymphovascular-invasion-in-bladder-cancer-ext 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-application-of-50-tesla-non-enhanced-mri-in-the-preoperative-assessment-of-renal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-ai-age-discrepancy-as-a-measure-of-frailty-in-kidney-tumor-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-serum-kidney-injury-molecule-1-with-treatment-response-and-survival-in-metastatic-ren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-silence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-dynamics-as-a-predictive-biomarker-of-response-and-survival-in-metastatic-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-dna-repair-gene-gdrg-variants-in-bcg-un-responsive-patients-a-potential-genetic-implicat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-androgen-deprivation-therapy-with-time-to-dementia-a-large-competing-risk-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-concordance-of-prostate-cancer-clinical-trials-and-disease-incidence-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-androgen-receptor-inhibitors-for-the-treatment-of-metastatic-castration-sensitive-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/membranous-and-cytoplasmic-nectin4-expression-and-outcomes-with-enfortumab-vedotin-plus-pembrolizuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metaproteomics-based-subtypes-in-muscle-invasive-bladder-carcinoma-and-association-with-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-darolutamide-monotherapy-in-patients-with-castration-sensitive-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanistic-insights-into-bacillus-calmette-guerin-bcg-sensitivity-in-non-muscle-invasive-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-early-quality-of-life-qol-changes-on-io-based-regimens-in-the-prospective-observational 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-rare-p16-expression-and-real-world-management-of-penile-cancer-in-bolivia-insights-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-treatment-approaches-on-survival-in-bulky-node-positive-penile-squamous-cell-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-treatment-patterns-in-patients-with-locally-advanced-or-metastatic-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-utilization-and-expenditure-burden-in-bladder-cancer-a-nationally-representative-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-enfortumab-vedotin-in-patients-with-advanced-urothelial-cancer-in-spain-the-enfa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-immune-related-adverse-events-iraes-and-treatment-discontinuation-rates-tdr-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-of-maintenance-oral-etoposide-versus-observation-following-high-dose-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-and-ipilimumab-maintenance-therapy-for-advanced-or-metastatic-urothelial-carcinoma-final 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-portos-gene-expression-signature-and-the-benefit-of-docetaxel-in-the-ecog-acrin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-docetaxel-in-combination-with-177-lutetium-psma-iampt-in-patients-with-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-among-patients-with-localized-prostate-cancer-lpc-undergoing-radical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-renal-cell-carcinoma-rcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-tislelizumab-in-combination-with-disitamab-vedotin-rc48-followed-by-distal-ureterectom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-metrics-and-clinical-outcomes-for-patients-with-metastatic-castration-resistant-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiation-dose-tailoring-guided-by-enhanced-targeting-radtarget-a-multi-center-randomized-control 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-results-from-the-eortc-1333peace-3-trial-enzalutamide-with-or-without-radiu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-co-occurrence-of-targetable-key-genomic-alterations-genalt-in-metastatic-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-sup177sup-lulu-psma-617 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-therapy-with-adt-darolutamide-and-biweekly-docetaxel-for-high-risk-metastatic-castration-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pam50-intrinsic-subtyping-and-decipher-genomic-classifier-in-biochemically-recurrent-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-multiparametric-prostate-mri-mpmri-vs-positive-biopsy-cores-on-risk-of-adverse-path 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-olaparib-combined-with-novel-hormone-therapy-in-metastatic-castration-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-variations-in-bladder-cancer-bc-clinical-trial-availability-within-the-united-states-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-lesion-location-and-avidity-on-baseline-psma-petct-as-predictor-of-duration-of-lu177-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/head-to-head-comparison-of-pembrolizumab-axitinib-versus-pembrolizumab-lenvatinib-in-metastatic-rcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-of-latin-american-oncologists-in-oral-sessions-at-the-asco-genitourinary-cancers-symp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-for-detection-of-ddr-gene-alterations-in-metastatic-prostate-cancer-mpc-diagnostic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-patients-characteristics-guiding-physicians-choice-of-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/polypharmacy-and-potential-drug-drug-interactions-with-novel-androgen-receptor-signaling-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-reprogramming-in-chromophobe-renal-cell-carcinoma-transcriptomic-insights-into-the-transi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-of-bladder-cancer-racial-and-socioeconomic-disparities-in-a-nationally-represent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-guided-disitamab-vedotin-combined-with-toripalimab-and-radiotherapy-for-multimodal-org 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspire-a-randomized-phase-iii-trial-of-androgen-deprivation-therapy-adt-plus-apalutamide-a-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-assessment-of-actinium-225-prostate-specific-membrane-antigen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-in-prostate-cancer-clinical-relevance-of-brca12-pathogenic-variant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rejoice-pantumor01-a-phase-2-signal-seeking-study-of-raludotatug-deruxtecan-r-dxd-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-cell-free-dna-methylation-as-a-predictive-biomarker-for-hormonal-therapy-response-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lu-177-dgul-in-a-phase-2-study-of-patients-with-metastatic-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetic-retinopathy-as-a-marker-for-renal-cell-carcinoma-among-patients-with-type-2-diabetes-mellit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-as-modifier-of-early-proteomic-remodeling-after-androgen-deprivation-therapy-adt-in-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-genomic-classifier-scores-and-initial-management-of-localized-prostate-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-of-primary-sarcoma-of-the-kidney-psk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-neoadjuvant-chemotherapy-guided-bladder-preservation-in-muscle-invasive-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-clinical-impact-of-germline-variants-in-dna-repair-genes-in-patients-who-underwent-curative-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-hypofractionated-radiotherapy-and-concomitant-oral-relugolix-for-treatment-of-intermediate-ris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-intravesical-gemcitabinedocetaxel-plus-systemic-pembrolizumab-in-high-risk-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-full-or-empty-for-pelvic-radiation-therapy-before-a-multi-center-randomized-controlled-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-ca9-and-psma-expression-in-clear-cell-renal-cell-carcinoma-ccrcc-and-the-effect-of-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-her2-ihc-on-enfortumab-vedotin-ev-or-evpembrolizumab-evp-benefit-in-metastatic-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-phase-ii-enfortumab-vedotin-plus-toripalimab-compared-to-gemcitabine-cispla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncological-outcomes-and-her2-expression-of-urothelial-carcinoma-with-squamous-differentiation-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-a-urinary-dna-methylation-biomarker-test-in-the-diagnosis-and-surveillance-of-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-long-term-remissions-possible-with-hormonal-therapy-only-post-hoc-analysis-of-embark-examining 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deferred-cytoreductive-nephrectomy-in-patients-with-advanced-rcc-treated-with-first-line-nivolumab-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-deep-learning-approach-for-predicting-chemotherapy-response-to-cisplatin-and-gemcitab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extra-pc-a-phase-ii-trial-of-masofaniten-epi-7386-and-enzalutamide-with-androgen-deprivation-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-of-for46-in-combination-with-enzalutamide-enza-in-patients-with-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-study-of-avzo-103-a-bispecific-nectin4trop2-antibody-drug-conjugate-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-durvalumab-in-completely-resected-early-stage-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-subsequent-therapies-post-enfortumab-vedotinpembrolizumab-evp-in-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-tumor-dna-utdna-and-circulating-tumor-dna-ctdna-in-patients-pts-with-muscle-invasive-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belzutifan-bel-plus-lenvatinib-lenva-versus-cabozantinib-cabo-for-advanced-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ev-prime-phase-ibii-study-of-enfortumab-vedotin-and-pembrolizumab-combined-with-radiotherapy-as-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-clinical-correlates-of-belzutifan-treatment-in-renal-cell-carcinoma-rcc-a-retrospecti-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-safety-efficacy-pharmacokinetics-pk-and-pharmacodynamics-pd-of-pasritamig-in-asian-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-exploring-genomic-correlates-of-clinical-outcome-in-patients-with-metastatic-cas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plant-based-dietary-indices-and-quality-of-life-in-men-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-quality-of-life-qol-with-novel-hormonal-therapy-nht-in-metastatic-castration-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-igg-a-novel-biomarker-for-efficacy-and-prognosis-in-metastatic-clear-cell-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-renal-cell-carcinoma-mortality-associated-with-tobacco-use-in-us-adults-aged-45-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-social-determinants-of-definitive-surgical-management-in-bladder-cancer-a-two-decade-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-tumor-mutational-burden-in-older-adults-75-years-with-bladder-cancer-a-tcg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-endpoints-as-surrogates-for-overall-survival-in-metastatic-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-among-lutetium-177-experienced-patients-with-metastatic-cas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-optimisation-and-psma-receptor-intensification-with-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-a-dose-escalation-study-evaluating-iclostridium-butyricumi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-tissue-free-ctdna-monitoring-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-computational-histology-artificial-intelligence-chai-prognostic-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-upper-tract-urothelial-carcinoma-utuc-with-or-without-sarcomatoid-diff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-depressive-symptoms-in-men-with-advance-prostate-cancer-pc-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-profile-of-darolutamide-adt-compared-to-enzalutamide-apalutamide-and-abiraterone-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etctn-10483-phase-ib-trial-of-erdafitinib-e-combined-with-enfortumab-vedotin-ev-following-prior 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aggressive-variant-prostate-cancer-features-and-therapeutic-outcomes-in-patients-with-de-novo-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-the-2025-nccn-update-in-defining-very-high-risk-prostate-cancer-on-surgical-outcomes-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-molecular-evolution-of-treatment-emergent-small-cellneuroendocrine-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-among-patients-with-metastatic-hormone-sensitive-prostate-cancer-in-contemporary-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-oncological-outcomes-of-prostate-cancer-upgrading-following-robot-assisted-radical-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-plus-pembrolizumab-pembro-in-participants-pts-with-advanced-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-abiraterone-versus-enzalutamide-on-depression-and-anxiety-in-hormone-sensitive-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-rising-psa-during-salvage-radiotherapy-post-radical-prostatectomy-on-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-correlating-the-clinical-phenotype-to-the-genotype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-cost-effectiveness-of-reduced-vs-full-initial-dose-androgen-receptor-signalin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-quality-of-life-endpoint-planning-and-reporting-in-phase-iii-genitourinary-oncology-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-pembrolizumab-p-with-response-guided-bladder-sparing-in-patients-with-muscle-inva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-frailty-and-quality-of-life-in-low-income-uninsured-men-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/p3bep-anzup-1302-an-international-randomized-phase-3-trial-of-accelerated-versus-standard-bep-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-delayed-cytoreductive-nephrectomy-in-patients-with-metastatic-clear-cell-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-of-belzutifan-in-pre-treated-renal-cell-carcinoma-a-real-world-retrospective-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tanker-70-tgf-v-receptor-type-2-knockout-allogeneic-nk-cells-for-renal-cell-carcinoma-expressing-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivonescimab-in-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-after-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-coexisting-amyloidosis-with-survival-outcomes-in-bladder-cancer-a-real-world-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytoshrink-a-randomized-phase-ii-trial-of-cytoreductive-stereotactic-hypofractionated-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-sup18sup-f-flotufolastat-pet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-first-line-1l-treatment-tx-patterns-and-overall-survival-os-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-genomic-dedifferentiation-signature-to-predict-clinical-outcomes-with-doublet-vs-triplet-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-in-resected-renal-cell-carcinoma-active-monitoring-vs-durvalumab-and-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-characterization-of-nectin-4-expression-in-penile-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-binary-dual-stain-immunohistochemistry-classifier-to-predict-pathologic-downstaging-after-neoadjuv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-it-time-to-redefine-the-phoenix-criterion-for-biochemical-failure-in-the-era-of-psma-petct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-cross-over-trial-to-assess-patient-preference-for-goserelin-microsphere-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomised-control-clinical-trial-of-radiotherapy-with-radiosensitisation-versus-intrave 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-luxar-02-phase-ii-study-of-luxdegalutamide-in-combination-with-sup177s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-enfortumab-vedotin-ev-plus-pembrolizumab-pembro-for-participants-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-ave-in-combination-with-other-anticancer-agents-as-first-line-maintenance-1lm-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fapfn1cav1-cancer-associated-fibroblast-subtype-and-its-association-with-aggressive-behavior-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gaps-in-brca-mutation-testing-among-mcrpc-patients-insights-from-us-cancer-practices-2018-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-associations-between-serum-oxo-androgens-race-and-radiographic-progression-free-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevpro-3-phase-iii-trial-of-mevrometostat-plus-enzalutamide-versus-placebo-plus-enzalutamide-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-concomitant-distant-lymph-node-metastases-in-metastatic-hormone-sensitive-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-comorbidity-as-a-predictor-of-poorer-survival-and-arpi-efficacy-in-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-psa-and-metastatic-prostate-cancer-at-presentation-in-the-united-states-from-2004-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-opinions-and-treatment-guidance-in-non-or-minimally-metastatic-testicular-cancer-is-chatgpt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-systemic-therapy-in-penile-cancer-a-single-center-experience-from-a-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-neoadjuvant-intravesical-mitomycin-c-therapy-administered-immediately-prior-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-assisted-eligibility-screening-for-prostate-cancer-clinical-trial-match 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-prostate-cancer-risk-groups-by-psma-pet-ppp3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-bolstering-outcomes-by-optimizing-immunotherapy-strategies-with-evolocumab-and-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-determinants-of-reproductive-organ-involvement-in-female-patients-undergoing-radical-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tulmistar-02-a-phase-iii-open-label-study-of-dose-escalation-and-expansion-of-tulmimetostat-in-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-environment-on-prostate-cancer-care-across-the-clinical-risk-spectrum-for-black-men 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-national-analysis-of-the-impact-of-opioid-use-disorder-on-clinical-outcomes-in-hospitalized-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncoeducate-a-pilot-study-of-generative-ai-to-support-patient-education-in-gu-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-outcomes-of-response-adapted-and-retreatment-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-term-intensified-pembrolizumab-and-tivozanib-for-high-risk-renal-cell-carcinoma-strike-alli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-and-synergistic-inhibition-of-the-polyadp-ribose-polymerase-and-androgen-receptor-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rucaparib-vs-docetaxel-dtx-or-second-generation-androgen-receptor-pathway-inhibitor-arpi-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-programmed-cell-death-protein-ligand-1-nuclear-translocation-mediated-by-enolase-on-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-radiographic-and-genomic-predictors-of-response-to-neoadjuvant-chemotherapy-for-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugates-in-genitourinary-malignancies-the-clinical-trial-landscape-and-emerging-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-value-of-tumor-response-and-survival-perceived-monetary-loss-in-anticancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-non-muscle-invasive-bladder-cancer-nmibc-genomic-score-ngs-to-predict-early-bcg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-treatment-tx-patterns-and-outcomes-in-patients-pts-with-locally-advanced-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-for-precision-oncology-moving-beyond-feasibility-and-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u03-substudy-03b-novel-investigative-regimens-for-previously-treated-advanced-clear-cell-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-phenotyping-and-trial-emulation-to-identify-checkpoint-inhibitor-responders-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-versus-6-months-of-adjuvant-oxaliplatin-fluoropyrimidine-chemotherapy-for-colorectal-cancer-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persian-trial-nct03449719-predictive-features-of-complete-biochemical-response-within-a-randomize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-artificial-intelligence-digital-pathology-algorithm-to-predict-outcomes-in-a-cohort-of-men-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-disparities-and-comorbidity-predictors-with-lu-177-psma-617-and-parp-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-sup177sup-lu-psma-617-in-chi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-prospective-single-center-phase-ii-study-on-modern-androgen-deprivation-therapy-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-without-causality-between-bap1-loss-and-the-metastasis-associated-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-and-variations-in-testicular-germ-cell-tumours-a-retrospective-real-world-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-multi-center-phase-ibii-trial-of-first-line-cadonilimab-plus-axitinib-in-advanced-n-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-natural-killer-nk-cell-axis-in-decoy-resistant-il18-treatment-in-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-heterogeneity-in-urothelial-carcinoma-with-trophoblastic-differentiation-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-outcomes-of-open-versus-robot-assisted-radical-nephrectomy-with-ivc-thrombectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rx-patterns-and-attrition-rates-in-patients-pts-with-metastatic-castration-resistant-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-body-composition-on-the-efficacy-of-chemotherapy-in-men-with-metastatic-aggressive-vari 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-asp5541-prl-02-a-long-acting-intramuscular-depot-injection-of-abiraterone-decano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-based-ultrasensitive-circulating-tumor-dna-clearance-as-a-biomarker-of-exceptional-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-platelet-polygenic-risk-score-to-predict-renal-cell-carcinoma-survival-via-sustained-thromb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-circulating-tumor-dna-profiling-in-patients-with-metastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/turning-the-tide-in-recurrent-nsgct-retrospective-insights-into-tip-vs-non-tip-salvage-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/icon-trial-phase-iii-trial-of-inulin-gel-in-combination-with-ipilimumab-and-nivolumab-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-symptomatic-hypoxia-in-a-high-altitude-cohort-of-patients-with-renal-cell-carcinoma-rc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-there-an-opportunity-for-checkpoint-inhibition-in-myc-amplified-castration-resistant-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-outcomes-following-sup177sup-lu-psma-617-lupsma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hospitalizations-on-health-related-quality-of-life-and-overall-survival-in-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-open-label-randomized-dose-finding-and-dose-expansion-study-of-gedatolisib-in-combina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-practice-of-active-surveillance-for-prostate-cancer-trends-variation-and-quality-within-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/establishment-and-characterization-of-a-panel-of-prostate-adenocarcinoma-xpdx-models-representing-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-liquid-biopsy-targeted-proteomic-assay-to-predict-outcomes-in-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-ibrcai-real-world-outcomes-with-polyadp-ribos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/topline-results-from-bond-003-cohort-p-a-multi-national-single-arm-study-of-intravesical-cretostim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-steroid-pretreatment-on-adverse-events-and-overall-survival-during-enfortumab-vedotin-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fgfr3-alterations-on-first-line-platinum-based-chemotherapy-in-patients-with-metastatic-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-and-timing-of-initiation-of-bone-targeting-agents-btas-in-patients-with-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-microenvironmental-nrg1-activation-of-her3-as-a-driver-of-resistance-to-pi3k-pathway-inhibitio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-prostate-cancer-subtyping-using-5hmc-sequencing-of-cell-free-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-evidence-based-risk-estimator-for-individualizing-benefit-and-response-in-oligometastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-neoadjuvant-chemotherapy-nac-use-in-stage-ii-iii-bladder-cancer-a-california-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-composite-biomarker-approach-to-withhold-neoadjuvant-chemotherapy-in-select-muscle-invasive-bladde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stockholm3-mri-population-based-screening-two-year-outcomes-comparing-stockholm3-and-psa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-in-adenocarcinoma-of-the-bladder-acb-impli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-investigation-of-the-cell-of-origin-and-oncogenic-pathways-across-variant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mir-371a-3p-as-a-potential-biomarker-for-monitoring-disease-activity-and-therapeutic-response-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-genomic-landscape-of-germline-exome-alterations-in-renal-cell-carcinoma-unclassified-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structured-step-based-prehabilitation-before-radical-cystectomy-and-its-impact-on-postoperative-reco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-disparities-in-the-availability-of-renal-cell-carcinoma-rcc-clinical-trials-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-computational-histology-artificial-intelligence-chai-powered-prognos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-prostate-specific-antigen-psa-doubling-time-dt-and-prostate-specific-membrane-ant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metformin-effects-on-renal-function-in-mcrpc-during-psma-radiopharmaceutical-therapy-rpt-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/availability-of-clinical-trials-investigating-prostate-cancer-pc-in-the-united-states-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/skeletal-related-event-impact-on-prostate-cancer-mortality-in-the-older-population-in-the-us-a-24-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consensus-guidance-on-early-identification-and-management-of-peripheral-neuropathy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-enfortumab-vedotin-plus-pembrolizumab-versus-platinum-based-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-burden-of-recurrence-among-older-adults-with-muscle-invasive-bladder-cancer-undergoing-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-metastatic-bladder-cancer-patients-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-ctdna-guided-adjuvant-atezolizumab-atezo-in-muscle-invasive-bladder-cancer-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthy-donor-fecal-microbiota-transplantation-combined-with-immunotherapy-in-metastatic-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/succinate-dehydrogenase-b-deficient-renal-cell-carcinoma-rcc-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-and-pembrolizumab-evp-outcomes-in-patients-pts-with-advanced-urothelial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/switch-androgen-receptor-pathway-inhibitor-strategies-in-metastatic-castration-resistant-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bleeding-risk-with-concurrent-anticoagulation-and-vegf-tki-therapy-in-mrcc-a-real-world-trinetx-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-androgen-production-uptake-and-conversion-apuc-genes-to-highlight-srd5 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-survival-and-prescription-patterns-of-darolutamide-versus-apalutamide-in-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-adherence-and-adverse-events-among-patients-with-advanced-prostate-cancer-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-feasibility-trial-investigating-inductive-apalutamide-therapy-combined-with-radical-prostatectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-spatial-analysis-of-the-tumor-immune-interface-in-localized-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-outcomes-in-aggressive-variant-prostate-cancer-treated-with-first-line-carboplatin-docetaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-baseline-serum-igg-in-metastatic-renal-cell-carcinoma-patients-undergoing-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-repair-hrr-mutation-in-de-novo-metastatic-hormone-sensitive-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-neoadjuvant-adt-duration-prior-to-radiotherapy-in-high-risk-prostate-cancer-rationale-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-performance-in-primary-retroperitoneal-lymph-node-dissection-a-stage-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-patients-pts-responding-to-enfortumab-vedotin-plus-pembrolizumab-evp-explo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-visit-educational-videos-on-clinic-efficiency-for-prostate-cancer-radiation-oncology-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-primary-chemoablation-with-ugn-102-in-different-eotrc-risk-groups 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-year-median-follow-up-update-of-bgb-a317-2002-iit-a-phase-2-study-of-neoadjuvant-tislelizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-outcomes-and-disease-free-survival-dfs-in-keynote-905-neoadjuvant-and-adjuvant-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-and-clinical-outcomes-of-renal-tumor-upstaging-from-ct1-to-pt3a-disease-in-patients-who-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhibiting-a26-sialylation-and-its-association-with-nectin-4-stability-and-macropinocytic-uptake-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-quality-of-life-measures-for-use-in-shared-decision-making-in-advanced-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-men-with-metastatic-castration-resistant-prostate-cancer-treated-with-olaparib-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-neutrophil-to-eosinophil-ratio-ner-in-patients-with-metastatic-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-urinary-tumor-dna-utdna-testing-guided-repeat-transurethral-resection-re-turb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-integration-of-vi-rads-radiomics-and-deep-learning-features-for-prediction-of-pathology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-optimal-mtap-homozygous-loss-homozygous-deletion-detection-in-urothelial-cancer-prevale 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-immune-checkpoint-inhibitor-ici-and-interval-from-ici-exposure-on-outcomes-with-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-adverse-events-aes-and-clinical-outcomes-in-first-line-enfortumab-vedotin-pembroliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-predictors-of-inpatient-palliative-care-utilization-in-metastatic-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omaha-003-phase-3-trial-of-cyp11a1-inhibitor-opevesostat-versus-androgen-receptor-pathway-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-and-expansion-of-ab001-in-patients-with-metastatic-castration-resistant-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guarding-the-kidneys-in-the-immunotherapy-era-pooled-incidence-and-severity-of-immune-related-nephr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-risk-classifier-performance-in-pet-guided-post-prostatectomy-patients-secondary-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ct-vs-15t-mr-guidance-in-salvage-radiotherapy-of-locally-recurrent-prostate-cancer-after-radical-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicohort-phase-2-trial-of-androgen-deprivation-therapy-adt-docetaxel-doce-and-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proliferation-and-immune-informed-fusion-of-multiscale-image-features-for-bladder-cancer-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cast-ai-cystectomy-after-systemic-therapy-with-adc-and-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-and-implementation-of-a-patient-centric-expanded-access-program-with-cretostimogene-grenadeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-enfortumab-vedotin-plus-pembrolizumab-followed-by-maintenance-pembrolizumab-in-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-clear-cell-renal-cell-carcinoma-ccrcc-patients-treated-with-belzutifan-stra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/front-line-1l-treatment-and-recurrence-patterns-among-patients-with-high-risk-non-muscle-invasive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-gemcitabine-plus-carboplatin-as-second-line-therapy-after-prior-enfortumab-vedoti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-and-chronic-gugi-toxicity-after-conventional-versus-hypofractionated-radiotherapy-hfrt-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-and-nectin-4-ihc-expression-and-clinical-outcomes-with-enfortumab-vedotin-plus-pembrolizumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/duplex-seq-derived-urinary-cell-free-dna-of-lynch-syndrome-patients-with-upper-tract-urothelial-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-molecular-mechanism-of-lymph-node-metastasis-driven-by-b-lymphocyte-foxo1-palmitoylation-induced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-ipilimumab-plus-nivolumab-followed-by-consolidating-chemoradiotherapy-as-bladder-sparing-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-nature-of-progression-on-active-surveillance-for-grade-group-2-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lutetium-lu-177-vipivotide-tetraxetan-on-prostate-cancer-outcomes-by-race 2026-08-24 monthly 0.7 https://rjrindex.com/articles/3-weekly-docetaxel-75-mgm-sup2sup-vs-2-weekly-docetaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-of-node-positive-m0-urothelial-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-risk-of-medication-related-osteonecrosis-of-the-jaw-and-survival-outcomes-with-rankl-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-treatment-outcomes-in-metastatic-prostate-cancer-with-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypervigilance-a-phase-ib-clinical-trial-to-optimize-risk-benefit-of-nezastomig-psmaxcd28-costimul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-combined-with-intravesical-electromotive-mitomycin-c-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-of-contemporary-immune-check-point-inhibitors-combinations-in-black-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasan-sparing-a-phase-2-trial-of-sasanlimab-maintenance-as-bladder-sparing-option-after-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-active-surveillance-in-young-men-with-low-risk-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-a-pathomics-signature-in-ide-novoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-associated-epigenetic-remodeling-under-androgen-deprivation-therapy-implications-for-cardio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-subsequent-therapy-in-patients-with-metastatic-renal-cell-carcinoma-of-intermediate-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opening-the-black-box-biologic-pathways-underlying-multimodal-digital-pathology-artificial-intellig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-analysis-in-participants-pts-with-advanced-clear-cell-renal-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-chemotherapy-retroperitoneal-lymph-node-dissection-for-patients-with-metastatic-pure-seminoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-a-post-prostatectomy-digital-pathology-based-multimodal-artificial-intelligence-mmai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adding-metformin-to-androgen-deprivation-therapy-adt-in-metastatic-hormone-sensitive-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intismeran-autogene-v940mrna-4157-plus-bacillus-calmette-guerin-bcg-versus-bcg-alone-for-high-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-first-line-1l-cabozantinib-c-versus-cabozantinib-with-ni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-plus-lenvatinib-in-advanced-renal-cell-carcinoma-interim-analysis-of-a-prospective-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-patients-with-locally-advanced-or-metastatic-urothelial-cancer-lamuc-in-fran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-use-of-angiotensin-converting-enzyme-inhibitors-acei-or-angiotensin-receptor-blockers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aggressive-variants-and-clinical-patterns-of-progression-in-real-world-metastatic-hormone-sensitive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-genomic-implications-of-her2-expression-in-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-177lu-psma-617-upstream-in-mcrpc-a-meta-analysis-of-randomized-trials-stratified-by-taxane 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-trial-of-eribulin-e-with-gemcitabine-vs-standard-of-care-soc-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-2427-single-arm-phase-ii-study-of-bladder-preservation-with-immunoradiotherapy-after-a-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-response-adapted-treatment-de-escalation-in-metastatic-urothelial-carcinoma-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-bladder-cancer-mortality-associated-with-tobacco-use-between-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-screening-uptake-and-predictors-of-elevated-prostate-specific-antigen-levels-in-sout 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-kinetics-as-a-biomarker-of-response-to-enfortumab-pembrolizumab-in-advanced-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-trial-design-factors-influencing-participation-in-prospective-bladder-and-kidney-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/db-1311bnt324-a-novel-b7h3-adc-in-patients-with-heavily-pretreated-mcrpc-from-a-phase-12-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-enriched-iyes1i-tumor-expression-at-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-clear-cell-subtype-for-kidney-tumors-from-cross-sectional-imaging-using-artificial-intell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-correlates-of-early-onset-clear-cell-renal-cell-carcinoma-eorcc-a-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kidney-injury-molecule1-kim-1-in-localized-and-metastatic-renal-cell-carcinoma-rcc-a-meta-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/educational-representation-of-genitourinary-malignancies-in-medical-student-curricula-a-cross-secti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-institutional-comparison-of-the-mir-371a-3p-assay-in-pre-surgical-germ-cell-tumor-gct-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-patterns-of-treatment-and-outcomes-in-germ-cell-tumors-across-a-provincial-cancer-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remodeling-of-the-periprostatic-adipose-microenvironment-in-aggressive-prostate-cancer-insights-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemis-003-a-phase-2-study-of-hs-20093-gsk5764227-in-patients-with-metastatic-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-prostate-cancer-and-mental-health-a-comparison-across-cancer-types-using-the-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-classification-of-foxa1-alterations-and-their-association-with-clinical-outcomes-in-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-large-language-models-llm-to-guide-adjuvant-treatment-recommendations-for-renal-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ecog-acrin-ea8192-cohort-c-a-phase-ii-trial-of-neoadjuvant-gemcitabinedurvalumab-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-ancestry-and-stage-specific-differences-in-prostate-cancer-genomic-alterations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-lutetium-177-dotatate-in-metastatic-prostate-cancer-with-neuroendocrine-differen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-for-grading-ctcae-toxicity-after-radiation-therapy-for-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-impact-of-the-medicare-prescription-payment-plan-for-medicare-part-d-beneficiaries-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-as-a-practical-decision-support-tool-for-oncologists-genitourinary-gu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imaging-meets-genomics-in-treatment-naive-prostate-cancer-suvmax-on-prostate-specific-membrane-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-quality-adjusted-time-without-symptoms-or-toxicity-q-twist-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-remote-exercise-on-fatigue-and-quality-of-life-qol-across-genitourinary-gu-cancer-type 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-sup18sup-f-flotufolastat-pet-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-dyadic-exercise-approach-to-prevent-declines-in-physical-and-mental-health-in-couples-during-radia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-intra-patient-contemporaneous-comparison-of-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-tolerability-of-ipilimumabnivolumab-in-older-70-years-versus-younger-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extracellular-vesicles-evs-and-circulating-tumor-dna-ctdna-as-potential-biomarkers-of-response-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fostering-inclusive-language-for-genitourinary-cancer-research-a-multi-stakeholder-co-creation-effo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u04-substudy-04b-first-line-1l-enfortumab-vedotin-ev-plus-pembrolizumab-pembro-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-phase-i-trial-of-an-implantable-microdevice-for-in-vivo-evaluation-of-drug-response-in-renal-c 2026-08-24 monthly 0.7